Philippine Sans
About Philippine Sans
Philippine Sans is a Product Manager specializing in Cell Therapy (CAR T) at Kite Pharma in Paris, France, where she has worked since 2020. She has a diverse background in public and industrial health, with experience in various roles across the healthcare sector.
Work at Kite Pharma
Philippine Sans has served as a Product Manager for Cell Therapy (CAR T) at Kite Pharma since 2020. Based in Paris, Île-de-France, France, she has focused on the management and development of CAR T therapies. Her role involves overseeing product performance and aligning strategies with the company's objectives in the cell therapy sector.
Education and Expertise
Philippine Sans holds a Master 2 (M2) in Public Affairs with a specialization in Public Health from Sciences Po Bordeaux, completed between 2014 and 2016. She also studied at Leipzig University, where she focused on Political Science and Government. Additionally, she obtained a Bachelor's degree in Political Science from Sciences Po Bordeaux and a Master 2 (M2) in Political Science and Comparative Sociology from Université de Bordeaux and Sciences Po Bordeaux, completed in 2017.
Background in Health Sectors
Philippine Sans has a diverse background in both public and industrial health sectors. She worked at the Ministry of Solidarity and Health, where she was involved in performance management for the General Directorate of Care Supply. Her experience also includes a role as Chargée de mission qualité et pertinence des parcours de soins, focusing on quality and relevance in healthcare pathways.
Previous Roles and Experience
Before her current position, Philippine Sans held various roles that contributed to her expertise in health and public service. She served as a municipal advisor at Mairie de Canéjan from 2014 to 2016. Additionally, she worked as a Senior Consultant in Health at Alcimed from 2017 to 2019 and as an educational interventionist at Complétude. She also completed an internship in strategic e-health consulting at Care Insight in 2017.